A Phase 2 Study to Evaluate the Safety and Efficacy of RM-131 in Patients With Parkinson's Disease & Chronic Constipation
Status:
Terminated
Trial end date:
2015-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study, called MOVE-PD, is to investigate how individuals with Parkinson's
disease (PD) and chronic constipation (CC) respond to RM-131 as compared to placebo. The
study will look at how well RM-131 affects the frequency of spontaneous bowel movements over
a 14-day period. The study will also evaluate the safety and tolerability of the study drug
and evaluate whether the study drug relieves the uncomfortable GI symptoms related to chronic
constipation in patients who are unsatisfied with other therapies they have tried for
constipation.
Phase:
Phase 2
Details
Lead Sponsor:
Motus Therapeutics, Inc.
Collaborator:
Michael J. Fox Foundation for Parkinson's Research